Read this article this morning:/prostatecancerinfolink.net/2016/06/07/will-restriction-spectrum-imaging-replace-multiparametric-mri/
Seems RSI-MRI has some promise, particularly for detecting GS6, which MPMRI doesn't do very well. It also is able to differentiate well between G3 and G4 PCa, and appears much more accurate when staging, doing a much better job of detecting EPE. Bullet points from the article:
RSI-MRI distinguished between cancer and benign tissue.
RSI-MRI distinguished between Gleason grade 3 and benign tissue.
RSI-MRI distinguished between Gleason grade 4 and benign tissue.
RSI-MRI distinguished between Gleason grade 3 and Gleason grade 4
It distinguished grades with geographic precision down to the voxel level
Glad to see continued innovation on MRI technologies specific to PCa!
Warm Regards-CJ-age 44
Dx 11/13@42YO - PSA 5.8, -DRE, GS6, MPMRI G-Bx@JH - 1/12 cores+@<5% - AS started
11/14@43YO - NIH T3 ERC-MPMRI, PSA 5.84, PSA-D 0.127
5/15@43YO - Bx, -DRE, PSA 6.41, 6/18 cores+, unilateral all G6@<5-75%
2/17 & 2/24/16 - HDB-m@FCCC, PSA 6.6, stage T1C, initial follow up appt@FCCC 6/16/16My Story